Post by GCI Health

As people are prioritizing living well over living long, is pharma keeping pace?  GCI Health’s research reveals that 72% of adults believe that modern medicine is better at extending life versus optimizing life.  In this article in Pharmaceutical Executive, GCI Health’s Kirsten Whipple discusses the new cultural mandate from lifespan (how long we live) to healthspan (how well we live). For pharma, this marks a shift from passive disease management. From the "Healthspan Hackers" to Gen Z's massive wellness spend, the demand for proactive, preventive care is rapidly rising.  Kirsten breaks down how pharma can shift from a life extender to a lifestyle partner in the burgeoning healthy aging market. Read the full article here: https://lnkd.in/guqT4-hM